A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

CompletedOBSERVATIONAL
Enrollment

566

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Rheumatoid Arthritis
Trial Locations (60)

10444

Site Reference ID/Investigator# 29989, Athens

11521

Site Reference ID/Investigator# 29953, Athens

Site Reference ID/Investigator# 30085, Athens

Site Reference ID/Investigator# 30472, Athens

11527

Site Reference ID/Investigator# 30479, Athens

Site Reference ID/Investigator# 30480, Athens

11528

Site Reference ID/Investigator# 29899, Athens

11635

Site Reference ID/Investigator# 30178, Athens

12134

Site Reference ID/Investigator# 29827, Peristeri

12462

Site Reference ID/Investigator# 30785, Athens

Site Reference ID/Investigator# 30788, Athens

13122

Site Reference ID/Investigator# 29992, Ágioi Anárgyroi

14500

Site Reference ID/Investigator# 30476, Kifissia

15343

Site Reference ID/Investigator# 47542, Ag. Paraskevi, Athens

15562

Site Reference ID/Investigator# 30789, Cholargós

17121

Site Reference ID/Investigator# 47544, Ag. Dimitrios, Athens

18454

Site Reference ID/Investigator# 29922, Nikaia

19200

Site Reference ID/Investigator# 29820, Elefsina

26221

Site Reference ID/Investigator# 29972, Pátrai

26335

Site Reference ID/Investigator# 29916, Pátrai

34100

Site Reference ID/Investigator# 30198, Chalcis

35100

Site Reference ID/Investigator# 29993, Lamia

41223

Site Reference ID/Investigator# 29988, Larissa

42100

Site Reference ID/Investigator# 30115, Trikala

43100

Site Reference ID/Investigator# 47322, Karditsa

45500

Site Reference ID/Investigator# 30482, Ioannina

47100

Site Reference ID/Investigator# 30118, Arta

50100

Site Reference ID/Investigator# 30004, Kozani

54622

Site Reference ID/Investigator# 29900, Thessaloniki

Site Reference ID/Investigator# 30192, Thessaloniki

54623

Site Reference ID/Investigator# 30165, Thessaloniki

54636

Site Reference ID/Investigator# 30765, Thessaloniki

54639

Site Reference ID/Investigator# 29845, Thessaloniki

54642

Site Reference ID/Investigator# 30791, Thessaloniki

Site Reference ID/Investigator# 30792, Thessaloniki

54643

Site Reference ID/Investigator# 47543, Thessaloniki

55134

Site Reference ID/Investigator# 29924, Thessaloniki

65302

Site Reference ID/Investigator# 30189, Kavala

66100

Site Reference ID/Investigator# 30105, Drama

67100

Site Reference ID/Investigator# 29968, Xánthi

68100

Site Reference ID/Investigator# 29915, Alexandroupoli

70013

Site Reference ID/Investigator# 30767, Heraklion Crete

71201

Site Reference ID/Investigator# 30008, Crete

74100

Site Reference ID/Investigator# 30210, Crete

Unknown

Site Reference ID/Investigator# 30116, A. Glyfada

Site Reference ID/Investigator# 29954, Ágioi Anárgyroi

Site Reference ID/Investigator# 29828, Crete

Site Reference ID/Investigator# 30146, Ermoupolis Syros

Site Reference ID/Investigator# 29850, Katerini

Site Reference ID/Investigator# 29936, Pýrgos

Site Reference ID/Investigator# 30084, Véria

115 21

Site Reference ID/Investigator# 29914, Athens

115 25

Site Reference ID/Investigator# 29950, Athens

Site Reference ID/Investigator# 5284, Athens

115 27

Site Reference ID/Investigator# 29944, Athens

Site Reference ID/Investigator# 30474, Athens

411 10

Site Reference ID/Investigator# 30770, Larissa

265 00

Site Reference ID/Investigator# 30200, Rion, Patras

564 29

Site Reference ID/Investigator# 30477, Thessaloniki

570 10

Site Reference ID/Investigator# 29947, Thessaloniki

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01086033 - A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece | Biotech Hunter | Biotech Hunter